Eric J Loumeau is CHIEF LEGAL OFFICER of ANAPTYSBIO, INC. Currently has a direct ownership of 8,947 shares of ANAB, which is worth approximately $302,587. The most recent transaction as insider was on Dec 22, 2025, when has been sold 10,000 shares (Common Stock) at a price of $51.0 per share, resulting in proceeds of $510,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.95K
1.55% 3M change
176.14% 12M change
Total Value Held $302,587

ERIC J LOUMEAU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2025
SELL
Open market or private sale
$510,000 $51.0 p/Share
10,000 Reduced 52.78%
8,947 Common Stock
Dec 22 2025
BUY
Exercise of conversion of derivative security
$140,200 $14.02 p/Share
10,000 Added 34.55%
18,947 Common Stock
Dec 18 2025
SELL
Open market or private sale
$6,625 $46.99 p/Share
141 Reduced 1.55%
8,947 Common Stock
Dec 17 2025
SELL
Open market or private sale
$460,000 $46.0 p/Share
10,000 Reduced 52.39%
9,088 Common Stock
Dec 17 2025
BUY
Exercise of conversion of derivative security
$140,200 $14.02 p/Share
10,000 Added 34.38%
19,088 Common Stock
Dec 16 2025
SELL
Open market or private sale
$562,000 $44.96 p/Share
12,500 Reduced 57.9%
9,088 Common Stock
Dec 16 2025
BUY
Exercise of conversion of derivative security
$213,625 $17.09 p/Share
12,500 Added 36.67%
21,588 Common Stock
Sep 30 2025
SELL
Open market or private sale
$238,960 $29.0 p/Share
8,240 Reduced 47.55%
9,088 Common Stock
Sep 30 2025
BUY
Exercise of conversion of derivative security
$70,100 $14.02 p/Share
5,000 Added 22.39%
17,328 Common Stock
Jan 06 2025
SELL
Payment of exercise price or tax liability
$33,920 $15.3 p/Share
2,217 Reduced 16.77%
11,003 Common Stock
Jan 06 2025
BUY
Exercise of conversion of derivative security
-
5,545 Added 29.55%
13,220 Common Stock
Jan 03 2025
SELL
Payment of exercise price or tax liability
$43,712 $14.6 p/Share
2,994 Reduced 28.06%
7,675 Common Stock
Jan 03 2025
BUY
Exercise of conversion of derivative security
-
7,288 Added 40.59%
10,669 Common Stock
Sep 17 2024
SELL
Open market or private sale
$145,189 $38.41 p/Share
3,780 Reduced 53.85%
3,240 Common Stock
Sep 16 2024
SELL
Open market or private sale
$344,701 $39.53 p/Share
8,720 Reduced 55.4%
7,020 Common Stock
Sep 16 2024
BUY
Exercise of conversion of derivative security
$70,100 $14.02 p/Share
5,000 Added 27.0%
13,520 Common Stock
Sep 14 2024
BUY
Exercise of conversion of derivative security
-
6,000 Added 35.84%
10,740 Common Stock
Feb 16 2024
SELL
Open market or private sale
$125,000 $25.0 p/Share
5,000 Reduced 60.68%
3,240 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
$70,100 $14.02 p/Share
5,000 Added 37.76%
8,240 Common Stock
Jan 08 2024
SELL
Open market or private sale
$50,272 $21.81 p/Share
2,305 Reduced 41.57%
3,240 Common Stock
Jan 06 2024
BUY
Exercise of conversion of derivative security
-
5,545 Added 50.0%
5,545 Common Stock
Nov 22 2023
SELL
Open market or private sale
$12,515 $14.19 p/Share
882 Reduced 100.0%
0 Common Stock
Sep 18 2023
SELL
Open market or private sale
$75,251 $19.32 p/Share
3,895 Reduced 81.54%
882 Common Stock
Sep 14 2023
SELL
Open market or private sale
$41,005 $19.48 p/Share
2,105 Reduced 30.59%
4,777 Common Stock
Sep 14 2023
BUY
Exercise of conversion of derivative security
-
6,000 Added 46.58%
6,882 Common Stock
EJL

Eric J Loumeau

CHIEF LEGAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on ANAB

Follow ANAPTYSBIO, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

News

Receive news related to ANAPTYSBIO, INC

Track Activities on ANAB